UNSPSC 51434954: Polythiazide/prazosin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434954 Polythiazide/prazosin, a Commodity code, captures pharmaceutical procurement by state and local health agencies, fire rescue departments, and cooperative purchasing alliances for emergency medications, generic multi-source drugs, and over-the-counter products. State and local buyers are soliciting inventory of specific injectable medications (epinephrine, adenosine, diltiazem, labetalol) for emergency medical services and broader pharmaceutical supply agreements through cooperative purchasing vehicles. The issuing bodies include municipal fire and rescue departments, state health agencies, and multistate cooperative purchasing alliances that serve state and local government facilities.

Activity is concentrated in Texas and Florida, with multistate reach through cooperative vehicles. The City of Tampa's Fire Rescue issued an IFB (Bid No. 26P00188) due April 8, 2026, for Advanced Life Support Medications—370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials—with an estimated contract value of $40,000 and a Small Local Business Enterprise sheltered market designation offering a 5 percent bid discount for SLBE participation. The Texas Health and Human Services Commission issued a Request for Information (RFI No. HHS0017013) on March 27, 2026, to gather vendor capabilities for direct-to-manufacturer pharmaceutical procurement, signaling future formal procurement activity. The Minnesota Department of Administration's Office of State Procurement, administering the multistate MMCAP vehicle, issued an RFP (S1070000015802) due March 26, 2026, for generic multi-source pharmaceuticals and OTC products across state and local government facilities, requiring vendors to maintain relationships with authorized wholesalers and comply with cGMP and DSCSA standards.